HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 17.711 ↓ -0.33%
[as on 27 March, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 27 March, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 0.33% -0.33% 1.16% -3.17% 0.04% 9.26%----
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -12.96% -2.07% -1.09% -8.7% -13.09% -8.96% 11.62% 15.36% 13.63% 14.88%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -12.61% -2.24% -0.95% -10.59% -12.07% -3.46% 12.26% 10.75% 11.9% 12.42%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 0.78% 1.53% 0.74% -1.67% 0.39% 2.66% 27.04% 18.94% 21.36% 13.22%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -10.47% -2.07% -2.16% -9.51% -9.75% -2.8% 18.56% 19.21% 17.71% 16.19%
SBI PSU Fund - DIRECT PLAN - GROWTH -2.2% -1.52% -2.43% -10.51% -0.18% 11.92% 32.82% 27.41% 19.26% 15.9%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 52.37% 1.73%

Discrete returns (monthly)

MonthMay 2025Jun 2025Jul 2025Aug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026
Returns 1.02% 3.88% 5.33% -1.45% -1.45% 2.16% 1.22% -1.38% -4.65% 6.99%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 6.02%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.31% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.69%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.70%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.87%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology6.67%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.05%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology5.83%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.49%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology4.12%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology3.80%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services3.71%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology3.63%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services3.61%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology3.50%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals & Biotechnology2.89%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology2.88%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology2.86%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services2.46%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.33%
Dr. Lal Path Labs LtdLALPATHLAB (INE600L01024)Healthcare Services1.88%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology1.78%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.72%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.68%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.58%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.50%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.29%
Pfizer Ltd.PFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.29%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology1.27%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology1.05%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies1.03%
Rubicon Research LimitedRUBICON (INE506V01022)Healthcare Services1.00%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services0.95%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology0.89%
Portfolio data is as on date 31 October, 2025

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history

DateNAV% change
27 March, 202617.711 -0.33%
25 March, 202617.77 1.94%
24 March, 202617.431 1.43%
23 March, 202617.186 -1.84%
20 March, 202617.508 1.16%
19 March, 202617.308 -2.29%
18 March, 202617.714 0.68%
17 March, 202617.595 0.63%
16 March, 202617.484 -0.64%
13 March, 202617.597 -2.52%
12 March, 202618.052 -0.52%
11 March, 202618.146 0.13%
10 March, 202618.122 1.28%
9 March, 202617.893 -0.88%
6 March, 202618.051 -0.06%
5 March, 202618.061 1.27%
4 March, 202617.835 -1.7%
2 March, 202618.144 -0.8%
27 February, 202618.291 -0.79%
26 February, 202618.436 1.07%
25 February, 202618.241 1.13%
24 February, 202618.037 0.03%
23 February, 202618.032 1%
20 February, 202617.854 -0.11%
19 February, 202617.873 -0.56%
18 February, 202617.973 0.31%
17 February, 202617.918 0.58%
16 February, 202617.814 0.77%
13 February, 202617.678 -1.56%
12 February, 202617.958

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 17.711 as on 27 March, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 0.33% as on 27 March, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 9.26% as on 27 March, 2026.